These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 14181915)

  • 1. [STUDY OF BLOOD COAGULATION FACTORS DURING GESTAGEN TREATMENT].
    SAS M; GABOR M; KOVACS L; NEMETH I; SZONTAGH F
    Orv Hetil; 1964 Jul; 105():1353-5. PubMed ID: 14181915
    [No Abstract]   [Full Text] [Related]  

  • 2. [STUDIES ON BLOOD COAGULATION FACTORS DURING GESTAGEN THERAPY].
    SAS M; GABOR M; KOVACS L; NEMETH I; SZONTAGH FE
    Arch Gynakol; 1964 Jun; 199():641-8. PubMed ID: 14240600
    [No Abstract]   [Full Text] [Related]  

  • 3. [Side effects of the oral contraceptive Ovosiston on the blood coagulation system].
    Carol W; Klinger G; Hempel E; Starker K; Quent P
    Zentralbl Gynakol; 1970 Dec; 92(50):1641-50. PubMed ID: 4099364
    [No Abstract]   [Full Text] [Related]  

  • 4. [BLOOD COAGULATION PHENOMENA IN THE COURSE OF TREATMENT WITH COMBINED VINYLESTRENOLONE AND ETHINYLESTRADIOL].
    MALAGOLI F; SIDERI L
    Gazz Med Ital; 1964 Apr; 123():116-8. PubMed ID: 14145737
    [No Abstract]   [Full Text] [Related]  

  • 5. CIRCULATION, BLOOD COAGULATION, AND CLINICAL OBSERVATIONS DURING HORMONAL SUPPRESSION OF OVULATION.
    BREHM H
    Int J Fertil; 1964; 9():45-56. PubMed ID: 14106268
    [No Abstract]   [Full Text] [Related]  

  • 6. [BLOOD COAGULATION CHANGES AND THEIR RELATION TO THE EFFECT OF DRUGS IN HYPERTENSION].
    URBANIUK KG
    Kardiologiia; 1964; 4():45-8. PubMed ID: 14203916
    [No Abstract]   [Full Text] [Related]  

  • 7. COAGULATION STUDIES IN EXTRACORPOREAL CIRCULATION.
    DYBKJAER E; BERG E; KISSMEYER-NIELSEN F
    Acta Chir Scand; 1964 Oct; 128():350-61. PubMed ID: 14211290
    [No Abstract]   [Full Text] [Related]  

  • 8. EXCRETION OF GONADOTROPINS AND 5-HYDROXYINDOLEACETIC ACID DURING NORMAL AND GESTAGEN-TREATED CYCLES.
    FUCHS AR; FUCHS F; JOHNSEN SG
    Int J Fertil; 1964; 9():139-45. PubMed ID: 14106247
    [No Abstract]   [Full Text] [Related]  

  • 9. [HORMONE EXCRETIONS AND BLOOD COAGULATION FACTORS DURING ORAL GESTAGEN-ESTROGEN THERAPY (EVALUATION OF THE RISK OF THROMBOPHLEBITIS)].
    HALLER J; KOENIG A; POLIWODA H
    Geburtshilfe Frauenheilkd; 1965 Mar; 25():215-31. PubMed ID: 14289766
    [No Abstract]   [Full Text] [Related]  

  • 10. Coagulation studies in women using combination type of oral contraceptives.
    Sharma S; Sharma M; Soni IJ; Gupta A; Jain R
    J Obstet Gynaecol India; 1983 Aug; 33(4):519-24. PubMed ID: 12339832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PROGESTIN-ESTROGEN (SC 11,800) THERAPY AND THE HEMOSTATIC MECHANISM--A CONTROLLED STUDY.
    MILLER SP; LEE SL; RITZ N
    Metabolism; 1965 Mar; 14():SUPPL:398-410. PubMed ID: 14261424
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyclical changes in coagulation factors associated with the use of progestational agents.
    McGrath KM; Castaldi PA
    Haemostasis; 1975; 4(2):73-80. PubMed ID: 1205338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormonal contraception and thromboembolic disease: effects of the oral contraceptives on hemostatic mechanisms. A review of the literature.
    Dugdale M; Masi AT
    J Chronic Dis; 1971 Mar; 23(10):775-90. PubMed ID: 4933752
    [No Abstract]   [Full Text] [Related]  

  • 14. The haemostatic mechanism in oral contraception.
    Hilden M; Amris CJ; Starup J
    Acta Obstet Gynecol Scand; 1967; 46(4):562-71. PubMed ID: 6082549
    [No Abstract]   [Full Text] [Related]  

  • 15. THE URINARY GONADOTROPIN CONTENT DURING TREATMENT WITH LYNESTRENOL.
    DEMOL R; FERIN J
    Int J Fertil; 1964; 9():197-203. PubMed ID: 14106257
    [No Abstract]   [Full Text] [Related]  

  • 16. [CLINICAL AND EXPERIMENTAL EXPERIENCES WITH HORMONAL OVULATION INHIBITORS].
    ERB H; KELLER M
    Gynaecologia; 1964; 158():1-17. PubMed ID: 14188602
    [No Abstract]   [Full Text] [Related]  

  • 17. INHIBITORY EFFECT OF LYNESTRENOL AND LYNDIOL ON HUMAN OVARIAN FUNCTION.
    BORGLIN NE
    Int J Fertil; 1964; 9():17-23. PubMed ID: 14106254
    [No Abstract]   [Full Text] [Related]  

  • 18. Coagulation and fibrinolytic studies during pregnancy.
    Nilsson IM; Kullander S
    Acta Obstet Gynecol Scand; 1967; 46(3):273-85. PubMed ID: 6073793
    [No Abstract]   [Full Text] [Related]  

  • 19. [ON CHANGES IN INDIVIDUAL BLOOD COAGULATION FACTORS FOLLOWING CHEMICAL THYROIDECTOMY AND AFTER THE TREATMENT WITH THYROID AND THYROTROPIC HORMONES].
    LUSZTIG G; JOZSA L; PERNECZKY M; SZEDERKENYI J
    Z Gesamte Inn Med; 1965 Jan; 20():9-14. PubMed ID: 14265532
    [No Abstract]   [Full Text] [Related]  

  • 20. OVULATION INHIBITION BY LYNDIOL: A CLINICAL TRIAL.
    TURPEINEN K
    Int J Fertil; 1964; 9():137-8. PubMed ID: 14106246
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.